🇮🇳 India Warehouse RUXOLITINIB — 10mg per tablet, 100-count pack. JAK1/JAK2 inhibitor for myelofibrosis, polycythemia vera, graft-versus-host disease, and alopecia areata. Jakavi brand most widely available internationally.
Key warning: Dose reduction in hepatic/renal impairment. TB screening before starting. Live vaccines contraindicated. Gradual tapering required. Interrupt for serious infections.
🇮🇳 India Warehouse RUXOLITINIB — 5mg per tablet, 100-count pack. JAK1/JAK2 inhibitor for myelofibrosis, polycythemia vera, graft-versus-host disease, and alopecia areata. Jakavi brand most widely available internationally.
Key warning: Dose reduction in hepatic/renal impairment. TB screening before starting. Live vaccines contraindicated. Gradual tapering required. Interrupt for serious infections.
🇮🇳 India Warehouse LENALIDOMIDE — 10mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 25mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENALIDOMIDE — 5mg per tablet, 120-count pack. IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
Key warning: TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🇮🇳 India Warehouse LENVATINIB — 10mg per tablet, 120-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LENVATINIB — 4mg per tablet, 120-count pack. Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
Key warning: Blood pressure monitoring from day 1. Hepatotoxicity monitoring. Hold 1 week before surgery. Embryofetal toxicity. QT prolongation monitoring.
🇮🇳 India Warehouse LETROZOLE — 2.5mg per tablet, 100-count pack. Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism.
Key warning: Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy.
🇮🇳 India Warehouse LETROZOLE — 2.5mg per tablet, 100-count pack. Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism.
Key warning: Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy.
🇮🇳 India Warehouse ONDANSETRON — 8mg per tablet, 100-count pack. 5-HT3 receptor antagonist antiemetic for chemotherapy-induced nausea/vomiting (CINV), post-operative nausea/vomiting (PONV), radiation-induced nausea, and pregnancy morning sickness.
Key warning: QT prolongation — avoid other QT-prolonging drugs, hypokalemia, hypomagnesemia, congenital QT syndrome. Not recommended in first trimester pregnancy by some guidelines.
🇮🇳 India Warehouse PALBOCICLIB — 125mg per tablet, 105-count pack. CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.
Key warning: CBC monitoring mandatory (weekly for first 2 cycles, monthly thereafter). Dose reductions for grade 3/4 neutropenia. QT prolongation risk. CYP3A4 substrate — multiple interactions. Embryofetal toxicity.
🇮🇳 India Warehouse FENBENDAZOLE — 150mg per tablet, 100-count pack. Veterinary anthelmintic gaining attention in cancer research following anecdotal reports and in vitro/animal studies showing anti-tumor activity. Not approved for human cancer treatment.
Key warning: NOT approved for human cancer treatment — off-label and investigational. Monitor liver function. No established human dosing protocol. Do not substitute for proven cancer treatments.
🇮🇳 India Warehouse FENBENDAZOLE — 3mg per tablet, 100-count pack. Veterinary anthelmintic gaining attention in cancer research following anecdotal reports and in vitro/animal studies showing anti-tumor activity. Not approved for human cancer treatment.
Key warning: NOT approved for human cancer treatment — off-label and investigational. Monitor liver function. No established human dosing protocol. Do not substitute for proven cancer treatments.
🇮🇳 India Warehouse PALBOCICLIB — 100mg per tablet, 105-count pack. CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.
Key warning: CBC monitoring mandatory (weekly for first 2 cycles, monthly thereafter). Dose reductions for grade 3/4 neutropenia. QT prolongation risk. CYP3A4 substrate — multiple interactions. Embryofetal toxicity.